Alzheimer’s Disease and Down Syndrome: What Families and Providers Have to Plan For

Alzheimer’s disease and Down syndrome: what families and providers have to plan for

Life expectancy for people with Down syndrome has gone from about 9 years in 1900 to about 28 in 1984 to roughly 60 today. It is one of the great quiet achievements of twentieth-century medicine, driven mostly by the surgical correction of congenital heart defects.

It has also stopped improving much, and there is a specific reason. The Advocate Health adult Down syndrome centre puts it bluntly: Alzheimer’s disease now appears to be the main factor preventing further increases in life expectancy.

This is the dominant adult health issue in Down syndrome. It arrives twenty or more years earlier than in the general population. It is handled badly in Australian disability services, not through indifference but because almost nothing in the system is designed for a person who develops dementia at 48 while living in a supported independent living house with six-monthly plan reviews and a rotating roster of casual staff.

This guide is about what to expect, what to document, and what the Australian funding and service landscape actually does — including one piece of good news that a surprising number of providers get wrong.

Why the risk is so high

Down syndrome is caused by an extra copy of chromosome 21. The gene for amyloid precursor protein — APP — sits on chromosome 21.

Amyloid precursor protein is the molecule that gets cleaved to produce beta-amyloid, the protein that accumulates as plaques in Alzheimer’s disease. An extra copy of the gene means extra APP across a lifetime, which means more beta-amyloid production from the beginning.

This is why Down syndrome is sometimes described as a genetically determined form of Alzheimer’s disease. In the general population, rare inherited APP variants cause early-onset familial Alzheimer’s. People with Down syndrome do not carry those variants — they simply have a third copy of the ordinary gene, running from conception.

The result, as the Alzheimer’s Association describes it, is that autopsy studies show that by age 40 the brains of almost all people with Down syndrome have significant levels of beta-amyloid plaques and tau tangles.

Note carefully what that sentence does and does not say. It says the pathology is essentially universal by 40. It does not say the dementia is. Plenty of people have the brain changes without developing symptoms, and the gap between pathology and clinical disease is where the interesting questions live.

The actual prevalence figures

Two sets of figures circulate and they are worth keeping separate, because people mix them and end up either terrified or complacent.

From the Alzheimer’s Association, citing the National Down Syndrome Society: about 30% of people with Down syndrome in their 50s have Alzheimer’s dementia, rising to about 50% in their 60s.

From the Global Down Syndrome Foundation’s adult guidelines, summarised in American Family Physician, with a finer age breakdown: about 9% of adults aged 45 to 50, and nearly one-third of those aged 55 to 59. Dementia is described as uncommon before 40.

Put those together and the shape of the curve is clear. Almost nothing before 40. Around one in eleven in the late forties. Roughly one in three by the late fifties. Around half in the sixties.

Which means two things at once, and both matter.

It is not inevitable. Half of people with Down syndrome in their sixties do not have Alzheimer’s dementia. A 50-year-old who seems to be changing is more likely to have something else going on than to be developing dementia, and the figures say so.

It is common enough to plan for by default. A provider supporting twenty adults with Down syndrome across the age range should expect to be supporting several people through dementia at any given time. A family with a 42-year-old son should be preparing, not because it will definitely happen but because the preparation is cheap and the alternative is improvising in a crisis.

The early signs are not memory loss

This is the single most practically important section of this guide, and it is where almost all the missed diagnoses come from.

In the general population, Alzheimer’s disease announces itself through memory. Someone forgets a conversation, loses the thread of a recipe, repeats a question. Families notice, and the pattern is recognisable because it is the cultural image of dementia.

In Down syndrome, the first changes are typically in function, personality and behaviour, and they come before obvious memory loss. The Alzheimer’s Association lists: reduced sociability, lower enthusiasm for usual activities, poor attention, irritability, sleep disturbances, and seizures beginning in adulthood.

Translate that into what a support worker actually sees:

• He used to put his jacket on when he heard the van. Now he has to be prompted twice.
• She used to lead the conversation at dinner. Now she watches.
• He has started resisting the shower, which he never did.
• She has stopped going into the kitchen to make her own toast — not refused, just stopped.
• He is awake at 2am, wandering, which is new.
• Her handwriting has changed.
• He had a seizure last month, and he has never had one before.

Every one of those gets written in shift notes as behaviour. Several of them get a behaviour support referral. Almost none of them get a dementia assessment, because nobody is thinking about dementia in a 49-year-old.

New-onset seizures in an adult with Down syndrome deserve particular attention. Epilepsy beginning in middle age in Down syndrome is strongly associated with Alzheimer’s pathology, and a first seizure at 50 in a person with Down syndrome should trigger a dementia assessment as well as a neurological workup.

The other reason this gets missed: as the Alzheimer’s Association notes, most adults with Down syndrome do not self-report memory concerns. The usual entry point to diagnosis — someone saying “I think I’m forgetting things” — is not available. Diagnosis depends entirely on other people noticing and reporting change, which depends entirely on those people having something to compare against.

The baseline, and why it is the one thing you must do

Experts recommend documenting baseline adult function by age 35.

We would go further: if you take one action from this guide, make it this one. Write down, in specific functional terms, what the person can currently do — and store it somewhere that will survive staff turnover, provider changes and house moves.

Why it matters so much: diagnosing dementia in a person with lifelong intellectual disability is genuinely difficult. Standard cognitive tests are designed for people with typical baseline cognition and they are not interpretable in isolation here. A score of 14 on some screening instrument tells you nothing if you do not know whether the person scored 14 or 24 at 30. The Alzheimer’s Association is explicit that cognitive tests should never be the only benchmark.

What a dementia diagnosis in Down syndrome actually rests on is documented change from that individual’s own baseline. No baseline, no diagnosis — or a diagnosis made years late, after the change has become undeniable.

A usable baseline is concrete and behavioural, not a score:

Add photographs and — this is underrated — short videos. Two minutes of the person eating dinner, walking down the hallway, and talking to a familiar person. In five years, when somebody is trying to establish whether gait or speech has changed, a video from when they were 38 is worth more than any amount of prose.

Store it in more than one place. Give the family a copy. Providers change.

Annual screening from 40

The Global Down Syndrome Foundation recommendation is specific: annual assessment of functional change from age 40, interviewing primary caregivers and reviewing six domains from the NTG-EDSD — the National Task Group Early Detection Screen for Dementia — to identify either early-stage Alzheimer’s-type dementia or a reversible medical cause.

Three features of that recommendation matter.

It starts at 40, which is before the prevalence curve really climbs. That is deliberate: it establishes a trend line.

It interviews the caregivers, not the person. The instrument is designed to capture observed change rather than test performance.

It explicitly looks for reversible causes as well. The screen is not a dementia test; it is a change-detection tool, and about half of what it catches will turn out to be something else.

The guidelines also caution against diagnosing Alzheimer’s-type dementia in adults under 40. Dementia that early does occur but it is unusual, and a 32-year-old losing skills is far more likely to have Down syndrome regression disorder, untreated sleep apnoea, hypothyroidism or depression. Getting that differential wrong is costly, because DSRD is often treatable and dementia is not.

The NTG-EDSD is free and publicly available. There is no good reason for an Australian disability provider supporting adults with Down syndrome over 40 not to be using it annually. In practice almost none do.

Rule out everything else first

Before anybody says dementia, the following must be excluded. The Alzheimer’s Association names thyroid problems, depression, chronic ear and sinus infections, vision loss and sleep apnoea specifically. In practice the list is longer:

• Hypothyroidism — 10 to 30 times more common in Down syndrome, presents exactly as cognitive slowing and apathy
• Obstructive sleep apnoea — prevalence approaching 100% in some adult series, causes reversible cognitive decline; see sleep apnoea and Down syndrome
• Depression — common, under-diagnosed, and the hardest to distinguish, because apathy and withdrawal look identical in both
• Hearing loss — progressive in Down syndrome; a person who stops responding may not be declining, they may not be hearing
• Vision loss — cataract occurs earlier, keratoconus is more common
• Pain — dental, musculoskeletal, reflux, constipation; in a person with limited language, pain presents as withdrawal and irritability
• Vitamin B12 and vitamin D deficiency
• Coeliac disease
• Medication effects, particularly anticholinergic load, which is a known and reversible cause of cognitive impairment and which accumulates quietly across prescriptions
• Cervical myelopathy — about one in ten adults with Down syndrome has atlantoaxial instability, and cord compression causes functional decline
• Life events — bereavement, a housemate moving out, a favourite worker leaving, a change of house. Adults with Down syndrome grieve, often with delayed onset and without the vocabulary to name it, and grief presents as functional decline

Depression deserves one more line because it is the commonest trap. Depression in Down syndrome can produce a near-total functional collapse that mimics dementia closely enough that the distinction is often made retrospectively — by whether the person responds to treatment. A trial of treatment for depression in an adult with Down syndrome who appears to be developing dementia is a reasonable clinical step rather than a delaying tactic.

The Australian funding point most providers get wrong

Here is the good news, and it needs saying clearly because we hear the opposite constantly.

An NDIS participant with Down syndrome who develops dementia before 65 stays in the NDIS. Dementia diagnosed before 65 is younger onset dementia, and it sits within the NDIS, not the aged care system. The test is age at diagnosis, not the nature of the condition and not the fact that dementia is usually thought of as an older person’s illness.

Given that dementia in Down syndrome typically appears in the forties and fifties, the overwhelming majority of people with Down syndrome who develop dementia will be well under 65 at diagnosis. They remain NDIS participants. Their plan changes; their system does not.

We have seen providers tell families that a dementia diagnosis means a transition to aged care. We have seen support coordinators start My Aged Care conversations about 51-year-olds. This is wrong and it does real harm, because the NDIS funds a level of individualised support that aged care does not.

The boundary rules, for completeness:

• You cannot join the NDIS after 65.
• An existing participant who turns 65 keeps their plan.
• The plan ends only if the person permanently enters residential aged care, or starts a permanent home care arrangement for the first time after 65.
• Since 1 November 2025, Support at Home has replaced Home Care Packages, with eight classifications, quarterly budgets and a care management fee. Clinical care is fully funded; personal care becomes fully government funded from 1 October 2026.
• The NDIS is not means tested. Aged care is.
• The move is generally one way.

So for a person with Down syndrome diagnosed with dementia at 52: they stay. For a person diagnosed at 67 who was never an NDIS participant: aged care, and My Aged Care on 1800 200 422. For a participant who turns 65 with dementia: they keep the plan, and the decision about residential aged care later is consequential and should not be made casually.

What the plan needs to change to

A dementia diagnosis in a person with Down syndrome changes the shape of the support, usually in this order.

Early stage. More prompting, more structure, more environmental cueing. Visual schedules where verbal instructions used to work. The same worker doing the same routine in the same order — consistency becomes clinically important rather than merely nice. Increased therapy input: occupational therapy at $193.99 per hour for environmental assessment and modification, speech pathology at the same rate as communication changes.

Middle stage. Support ratio changes. Someone who managed with drop-in support needs continuous presence. Someone in a 1:3 shared arrangement may need 1:1 for parts of the day. Overnight support becomes a question, and this is where the money moves: a sleepover at the flat 2026–27 rate of $311.79 per night is very different from active overnight support at $82.57 per hour, which over a year is roughly $163,000 of difference. The clinical trigger for that change is usually night waking, wandering or continence change.

Later stage. Mobility decline, dysphagia, continence, seizures. High intensity support skills come into play — dysphagia management and complex bowel care are both on the High Intensity Support Skills Descriptors list, which carries competency and supervision requirements for workers. Registered nursing at $128.05 per hour may enter the picture. Our high intensity supports guides cover what the provider obligations actually are.

Environment. This is the piece families most often miss and it is worth planning early. A house that works for a 45-year-old with Down syndrome frequently does not work for the same person at 55 with dementia. Stairs become a problem. A bathroom that required agility becomes unusable. Wayfinding matters: contrasting colours on door frames, a visible toilet, reduced visual clutter, consistent lighting without glare. Home modification funding takes time to approve and longer to build, so the occupational therapy assessment should happen in the early stage, not when the person has already had three falls.

And the question nobody raises early enough: will this person be able to stay in this house? The honest answer in Australian supported independent living is often no — because the house has stairs, or because the other residents cannot live alongside night-time wandering, or because the provider cannot staff the change. Having that conversation at diagnosis, while there is time to plan a move properly or modify the house, is enormously better than having it after an incident. Supported independent living with Down syndrome goes into what dementia-ready housing looks like.

Being honest about the trajectory

We are not going to end this with an upbeat paragraph, because families deserve better than that.

Alzheimer’s disease in Down syndrome tends to progress faster than in the general population once it starts. There is no treatment that stops it. The anti-amyloid therapies now reaching the market have not been established as safe or effective in Down syndrome, and people with Down syndrome have been largely excluded from the trials — which is its own scandal given that this is the highest-risk group in the world. Research is under way, including through the Horizon 21 European consortium, and that is worth watching.

What does help: treating everything treatable, keeping the person physically well, maintaining routine and relationships, adapting the environment early, managing pain properly, and being on the front foot with the plan rather than reactive.

And the thing that helps most is the least clinical. The people who do best are the ones surrounded by staff and family who knew them before, who can tell when something is wrong because they remember what right looked like, and who do not reach for a behaviour explanation when a person who has always been cheerful in the mornings starts crying at 7am.

That is largely a function of continuity of staffing, which is a funding and workforce question, which is not something a family can fix. But it is worth knowing it is the variable that matters, and worth weighting heavily when you choose a provider.